Industries > Pharma > Pharma Clinical Trial Services Market and Industry Forecast 2017-2027

Back to Pharma Reports

Pharma Clinical Trial Services Market and Industry Forecast 2017-2027

Early Phase Services, Late Phase Services, Other Services, Pharma, Biotech, Other End-Users, Cancer, Cardiovascular Diseases, CNS, Infectious Diseases, Metabolic Diseases, Other Diseases

PUBLISHED: 11 July 2017

PAGES: 188

PRODUCT CODE: PHA0210

SUBMARKET: Contract Services Drug Discovery Development & Production Pharma Therapeutic Drugs

SKU: PHA0210 Categories: Contract Services, Drug Discovery Development & Production, Pharma, Pharma, Therapeutic Drugs Tag: PHA0415

The pharma clinical trial services market is expected to grow at a CAGR of 9.5% in the first half of the forecast period. The market is expected to grow at a CAGR of 9.8% from 2016-2027. The pharma clinical trial services market is estimated at $39.56bn in 2016 dominated by the late-phase services, which held 56% of share.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 188-page report you will receive 145 charts – all unavailable elsewhere.

The 188-page report provides clear detailed insight into the pharma clinical trial services market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

Report Scope

• Pharma Clinical Trial Services Market forecasts from 2017-2027

• This report breaks down the revenue forecast for pharma clinical trial services market by type of service:
• Early Phase Services
• Late Phase Services
• Other Services

Each submarket is further divided by region: North America, Europe, Asia-Pacific and RoW

• This report breaks down the revenue forecast for pharma clinical trial services market by End-Users:
• Pharma
• Biotech Companies
• Other End-Users

Each submarket is further divided by region: North America, Europe, Asia-Pacific and RoW
• This report breaks down the revenue forecast for pharma clinical trial services market by Therapeutic Area:
• Cancer
• Cardiovascular
• CNS
• Infectious Diseases
• Metabolic Diseases
• Other Diseases

Each submarket is further divided by region: North America, Europe, Asia-Pacific and RoW

• This report provides individual revenue forecasts to 2027 for these regional and national markets:
• North America: the US and Rest of North America
• Europe: France, Germany, the UK, Spain, Italy, Russia, Central and Eastern Europe, Rest of Europe
• Asia-Pacific: China, India, Japan, South Korea, Rest of APAC
• Rest of the World: Latin America, Middle East and Africa, Brazil

Each regional market is further divided by type of service, end-users and therapeutic area.

• Our study discusses factors that drive and restrain the pharma clinical trial services market. This report also provides a STEP analysis

• This report discusses the leading companies in pharma clinical trial services market:
• Quintiles IMS Holdings Inc.
• LabCorp (Covance Inc.)
• Pharmaceutical Product Development (PPD), LLC
• Parexel International Corporation
• ICON
• INC Research
• inVentiv Health
• PRA Health Sciences
• Chiltern International
• Charles River Laboratories

Visiongain’s study is intended for anyone requiring commercial analyses for the pharma clinical trial services market. You find data, trends and predictions.

Buy our report today Pharma Clinical Trial Services Market and Industry Forecast 2017-2027: Early Phase Services, Late Phase Services, Other Services, Pharma, Biotech, Other End-Users, Cancer, Cardiovascular Diseases, CNS, Infectious Diseases, Metabolic Diseases, Other Diseases.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

1. Report Overview

1.1 Global Pharma Clinical Trial Services Market Overview

1.2 Why You Should Read This Report

1.3 Key Questions Answered by This Analytical Report

1.4 Structure of the Report

1.5 Who is This Report For?

1.6 Methodology

1.7 Frequently Asked Questions (FAQ)

1.8 Associated Visiongain Reports

1.9 About Visiongain

2. Pharma Clinical Trial Services Market Introduction

2.1 Clinical Trials: A Historical Perspective

2.2 Design and Execution of Clinical Trials

2.3 Phases of Clinical Trials

2.3.1 Phase I Trials: First In-Human Studies

2.3.2 Phase II Trials: Proof-of- Concept

2.3.3 Phase III Trials: Drug Approval Applications

2.3.4 Post-Marketing Studies

2.3.5 Key Elements of Clinical Trials

2.4 Common Trial Designs

2.4.1 Improving Clinical Trial Models through Adaptive Trial Designs

2.5 Clinical Trial Outsourcing

2.5.1 Challenges Exist in Conducting Clinical Trials

2.5.2 Benefits of Outsourcing

3. Pharma Clinical Trial Services: World Market by Services 2016-2027

3.1 The Impact of Economy on the Clinical Trial Services Market 2017-2027

3.2 Pharma Clinical Trial Services Market by Services 2017-2027

3.2.1 Early Phase Clinical Trial Services Market Forecasts 2017-2027

3.2.2 Late Phase Clinical Trial Services Market Forecasts 2017-2027

3.2.3 Other Clinical Trial Services Market Forecasts 2017-2027

4. Pharma Clinical Trial Services: World Market by End-Users 2016-2027

4.1 The Evolution of the Clinical Research Organizations (CROs)

4.2 Pharma Clinical Trial Services Market by End-Users 2017-2027

4.2.1 Clinical Trial Services Market by Pharma End-Users Forecasts 2017-2027

4.2.2 Clinical Trial Services Market by Biotech Companies End-Users Forecasts 2017-2027

4.2.3 Clinical Trial Services Market by Other End-Users Forecasts 2017-2027

5. Pharma Clinical Trial Services: World Market by Therapeutic Areas 2017-2027

5.1 Rise of Clinical Trial Services in Key Therapeutic Areas

5.1.1 Cancer Clinical Trial Services Market Forecasts 2017-2027

5.1.2 Cardiovascular Diseases Clinical Trial Services Market Forecasts 2017-2027

5.1.3 CNS Diseases Clinical Trial Services Market Forecasts 2017-2027

5.1.4 Infectious Diseases Clinical Trial Services Market Forecasts 2017-2027

5.1.5 Metabolic Diseases Clinical Trial Services Market Forecasts 2017-2027

5.1.6 Other Diseases Clinical Trial Services Market Forecasts 2017-2027

6. Regional Pharma Clinical Trial Services Market Forecasts 2017-2027

6.1 North American Pharma Clinical Trial Services Market Forecasts 2017-2027

6.1.1 U.S. Pharma Clinical Trial Services Market Forecasts 2017-2027

6.1.2 Rest of North America Pharma Clinical Trial Services Market Forecasts 2017-2027

6.2 North American Pharma Clinical Trial Services Market Forecasts by Service 2017-2027

6.3 North American Pharma Clinical Trial Services Market Forecasts by Therapeutic Area 2017-2027

6.4 North American Pharma Clinical Trial Services Market Forecasts by End-Users 2017-2027

6.5 Europe Pharma Clinical Trial Services Market Forecasts 2017-2027

6.5.1 France Pharma Clinical Trial Services Market Forecasts 2017-2027

6.5.2 Germany Pharma Clinical Trial Services Market Forecasts 2017-2027

6.5.3 U.K. Pharma Clinical Trial Services Market Forecasts 2017-2027

6.5.4 Spain Pharma Clinical Trial Services Market Forecasts 2017-2027

6.5.5 Italy Pharma Clinical Trial Services Market Forecasts 2017-2027

6.5.6 Russia Pharma Clinical Trial Services Market Forecasts 2017-2027

6.5.7 Central and Eastern Europe Pharma Clinical Trial Services Market Forecasts 2017-2027

6.5.8 Rest of Europe Pharma Clinical Trial Services Market Forecasts 2017-2027

6.6 European Pharma Clinical Trial Services Market Forecasts by Service 2017-2027

6.7 European Pharma Clinical Trial Services Market Forecasts by Therapeutic Area 2017-2027

6.8 European Pharma Clinical Trial Services Market Forecasts by End-Users 2017-2027

6.9 Asia-Pacific Pharma Clinical Trial Services Market Forecasts 2017-2027

6.9.1 China Pharma Clinical Trial Services Market Forecasts 2017-2027

6.9.2 India Pharma Clinical Trial Services Market Forecasts 2017-2027

6.9.3 Japan Pharma Clinical Trial Services Market Forecasts 2017-2027

6.9.4 South Korea Pharma Clinical Trial Services Market Forecasts 2017-2027

6.9.5 Rest of Asia-Pacific (APAC) Pharma Clinical Trial Services Market Forecasts 2017-2027

6.10 Asia-Pacific Pharma Clinical Trial Services Market Forecasts by Service 2017-2027

6.11 Asia-Pacific Pharma Clinical Trial Services Market Forecasts by Therapeutic Area 2017-2027

6.12 Asia-Pacific Pharma Clinical Trial Services Market Forecasts by End-Users 2017-2027

6.13 Rest of the World (RoW) Pharma Clinical Trial Services Market Forecasts 2017-2027

6.13.1 Latin America Pharma Clinical Trial Services Market Forecasts 2017-2027

6.13.2 Middle East and Africa Pharma Clinical Trial Services Market Forecasts 2017-2027

6.13.3 Brazil Pharma Clinical Trial Services Market Forecasts 2017-2027

6.14 Rest of the World (RoW) Pharma Clinical Trial Services Market Forecasts by Service 2017-2027

6.15 Rest of the World (RoW) Pharma Clinical Trial Services Market Forecasts by Therapeutic Area 2017-2027

6.16 Rest of the World (RoW) Pharma Clinical Trial Services Market Forecasts by End-Users 2017-2027

7. Drivers & Restraints

7.1 Drivers and Restraints 2017-2027

7.2 Drivers

7.2.1 Increased research and development by biopharmaceutical companies leading to better utilization of clinical trial services

7.2.2 Contract research organizations present in the emerging markets to gain major foothold in the forecast period

7.2.3 Growth of biopharma R&D expenditures will lead to increase in the clinical trial market

7.2.4 Emerging markets especially China becoming a much sought-after clinical trial destination

7.2.5 Increased Strategic Alliances among Large BioPharma Companies and CROs benefitting the market

7.3 Restraints

7.3.1 Regulatory Constraints such as longer approval time for clinical trials

7.3.2 Poor Physician and Nurse Engagement Leading to Low Patient Recruitment Rates

8. Leading Companies in the Pharma Clinical Trial Services Market

8.1 Quintiles IMS Holdings Inc.

8.1.1 Quintiles IMS Holdings Inc. Business Overview

8.1.2 Quintiles IMS Holdings Inc. Financial Overview

8.1.3 Quintiles IMS Holdings Inc. Corporate Strategy

8.2 LabCorp (Covance Inc.)

8.2.1 LabCorp Business Overview

8.2.2 LabCorp Financial Overview

8.2.3 LabCorp (Covance Inc.) Corporate Strategy

8.3 Pharmaceutical Product Development (PPD), LLC

8.3.1 Pharmaceutical Product Development (PPD) Business Overview

8.3.2 Pharmaceutical Product Development (PPD) Financial Overview

8.3.3 Pharmaceutical Product Development (PPD) Corporate Strategy

8.4 Parexel International Corporation

8.4.1 Parexel International Corporation Business Overview

8.4.2 Parexel International Corporation Financial Overview

8.4.3 Parexel International Corporation Corporate Strategy

8.5 ICON

8.5.1 ICON Business Overview

8.5.2 ICON Financial Overview

8.5.3 ICON Corporate Strategy

8.6 INC Research

8.6.1 INC Research Business Overview

8.6.2 INC Research Financial Overview

8.6.3 INC Research Corporate Strategy

8.7 inVentiv Health

8.7.1 inVentiv Health Business Overview

8.7.2 inVentiv Health Financial Overview

8.7.3 inVentiv Health Corporate Strategy

8.8 PRA Health Sciences

8.8.1 PRA Health Sciences Business Overview

8.8.2 PRA Health Sciences Financial Overview

8.8.3 PRA Health Sciences Corporate Strategy

8.9 Chiltern International

8.9.1 Chiltern International Business Overview

8.9.2 Chiltern International Financial Overview

8.9.3 Chiltern International Corporate Strategy

8.10 Charles River Laboratories

8.10.1 Charles River Laboratories Business Overview

8.10.2 Charles River Laboratories Financial Overview

8.10.3 Charles River Laboratories Corporate Strategy

9. STEP Analysis of the Pharma Clinical Trial Services Market 2017-2027

9.1 STEP Analysis of the Pharma Clinical Trial Services Market

9.2 Social Factors Affecting Clinical Trials

9.2.1 Ethical Considerations in Conducting Clinical Trials

9.2.2 Patient Recruitment: Major Challenge in Developed Markets

9.3 Technological Development for Improved Trials

9.3.1 Electronic Data Capture

9.3.2 eClinical Trial Tools

9.3.3 Use of Electronic Health Records for Faster Patient Recruitment

9.3.4 Cloud Computing used as a Tool for Multicentre Trials

9.4 Economic Considerations for Clinical Trial Outsourcing

9.4.1 Pharma is adjusting its R&D strategies

9.4.2 CROs tend to be attractive for Private Investigators

9.5 Political and Regulatory Considerations for Clinical Trial Outsourcing

9.5.1 Drug Safety and Clinical Trials Post-Approval

9.5.2 Cutting Red Tape and Other Regulatory Developments

10. Conclusions

10.1 Current Leading Pharma Clinical Trial Services Market Segments

10.1.1 Leading Contract Research Organizations

10.1.2 Leading Regional Markets

10.1.3 Emerging Pharma Clinical Trial Services Markets

Appendices

Glossary

Visiongain Report Sales Order Form

About Visiongain

Visiongain report evaluation form

List of Figures

Figure 2.1 Brief History of Clinical Trials

Figure 3.1 Breakdown of Pharma Clinical Spending by Phase

Figure 3.2 Global Pharma Clinical Trial Services Market by Services: (% Share), 2016

Figure 3.3 Pharma Clinical Trial Services Market by Services: Revenue ($bn), 2016-2027

Figure 3.4 Early Phase Services Market Forecasts: AGR (%), 2017-2027

Figure 3.5 Global Early Phase Clinical Trial Services Market by Region: Revenue ($bn), 2016-2027

Figure 3.6 Global Early Phase Clinical Trial Services Market Share by Region: (% Share), 2016-2027

Figure 3.7 Late Phase Clinical Trial Services Market Forecasts: AGR (%), 2017-2027

Figure 3.8 Global Late Phase Clinical Trial Services Market by Region: Revenue ($bn), 2016-2027

Figure 3.9 Global Late Phase Clinical Trial Services by Region: (% Share), 2016-2027

Figure 3.10 Other Pharma Clinical Trial Services Submarket Forecasts: AGR (%), 2017-2027

Figure 3.11 Global Other Pharma Clinical Trial Services Market by Region: Revenue ($bn), 2016-2027

Figure 3.12 Global Other Pharma Clinical Trial Services by Region: (% Share), 2016-2027

Figure 4.1 Pharma Clinical Trial Services Submarkets by End-Users: Revenue ($bn), 2016-2027

Figure 4.2 Clinical Trial Services Pharma Submarket: AGR (%), 2017-2027

Figure 4.3 Global Clinical Trial Services Pharma Submarket by Region: Revenue ($bn), 2016-2027

Figure 4.4 Global Clinical Trial Services Pharma Submarket by Region: (% Share), 2016-2027

Figure 4.5 Clinical Trial Services Biotech Companies Submarket: AGR (%), 2017-2027

Figure 4.6 Global Clinical Trial Services Biotech Companies Submarket by Region: Revenue ($bn), 2016-2027

Figure 4.7 Global Clinical Trial Services Biotech Companies Submarket by Region: (% Share), 2016-2027

Figure 4.8 Clinical Trial Services Other End-Users Submarket: AGR (%), 2017-2027

Figure 4.9 Global Clinical Trial Services Other End-Users Submarket by Region: Revenue ($bn), 2016-2027

Figure 4.10 Global Clinical Trial Services Other End-Users Submarket by Region: (% Share), 2016-2027

Figure 5.1 Global Pharma Clinical Trial Services Market by Therapeutic Area: (% Share), 2016

Figure 5.2 Pharma Clinical Trial Services Submarkets by Therapeutic Area: Revenue ($bn), 2016-2027

Figure 5.3 Cancer Clinical Trial Services Submarket: AGR (%), 2017-2027

Figure 5.4 Global Cancer Clinical Trial Services Submarket by Region: Revenue ($bn), 2016-2027

Figure 5.5 Global Cancer Clinical Trial Services Submarket by Region: (% Share), 2016-2027

Figure 5.6 Cardiovascular Diseases Clinical Trial Services Submarket: AGR (%), 2017-2027

Figure 5.7 Global Cardiovascular Diseases Clinical Trial Services Submarket by Region: Revenue ($bn), 2016-2027

Figure 5.8 Global Cardiovascular Diseases Clinical Trial Services Submarket by Region: (% Share), 2016-2027

Figure 5.9 CNS Diseases Clinical Trial Services Submarket: AGR (%), 2017-2027

Figure 5.10 Global CNS Diseases Clinical Trial Services Submarket by Region: Revenue ($bn), 2016-2027

Figure 5.11 Global CNS Diseases Clinical Trial Services Submarket by Region: (% Share), 2016-2027

Figure 5.12 Infectious Diseases Clinical Trial Services Submarkets: AGR (%), 2017-2027

Figure 5.13 Global Infectious Diseases Clinical Trial Services Submarket by Region: Revenue ($bn), 2016-2027

Figure 5.14 Global Infectious Diseases Clinical Trial Services Submarket by Region: (% Share), 2016-2027

Figure 5.15 Metabolic Diseases Clinical Trial Services Submarkets: AGR (%), 2017-2027

Figure 5.16 Global Metabolic Diseases Clinical Trial Services Submarket by Region: Revenue ($bn), 2016-2027

Figure 5.17 Global Metabolic Diseases Clinical Trial Services Submarket by Region: (% Share), 2016-2027

Figure 5.18 Other Diseases Clinical Trial Services Submarket: AGR (%), 2017-2027

Figure 5.19 Global Other Diseases Clinical Trial Services Submarket by Region: Revenue ($bn), 2016-2027

Figure 5.20 Global Other Diseases Clinical Trial Services Submarket by Region: (% Share), 2016-2027

Figure 6.1 Regional Pharma Clinical Trial Services Markets: Revenue ($bn), 2017-2027

Figure 6.2 North American Pharma Clinical Trial Services by Country: (% Share), 2016

Figure 6.3 U.S. Pharma Clinical Trial Services Market: Revenue ($bn), 2016-2027

Figure 6.4 Rest of North America Pharma Clinical Trial Services Market: Revenue ($bn), 2016-2027

Figure 6.5 North American Pharma Clinical Trial Services Market by Service: Revenue ($bn), 2016-2027

Figure 6.6 North American Pharma Clinical Trial Services Market by Therapeutic Area: Revenue ($bn), 2016-2027

Figure 6.7 North American Pharma Clinical Trial Services Market by End-Users: Revenue ($bn), 2016-2027

Figure 6.8 European Pharma Clinical Trial Services by Country: (% Share), 2016

Figure 6.9 France Pharma Clinical Trial Services Market: Revenue ($bn), 2016-2027

Figure 6.10 Germany Pharma Clinical Trial Services Market: Revenue ($bn), 2016-2027

Figure 6.11 U.K. Pharma Clinical Trial Services Market: Revenue ($bn), 2016-2027

Figure 6.12 Spain Pharma Clinical Trial Services Market: Revenue ($bn), 2016-2027

Figure 6.13 Italy Pharma Clinical Trial Services Market: Revenue ($bn), 2016-2027

Figure 6.14 Russia Pharma Clinical Trial Services Market: Revenue ($bn), 2016-2027

Figure 6.15 Central and Eastern Europe (CEE) Pharma Clinical Trial Services Market: Revenue ($bn), 2016-2027

Figure 6.16 Rest of Europe Pharma Clinical Trial Services Market: Revenue ($bn), 2016-2027

Figure 6.17 European Pharma Clinical Trial Services Market by Service: Revenue ($bn), 2016-2027

Figure 6.18 European Pharma Clinical Trial Services Market by Therapeutic Area: Revenue ($bn), 2016-2027

Figure 6.19 European Pharma Clinical Trial Services Market by End-users: Revenue ($bn), 2016-2027

Figure 6.20 Asia-Pacific Pharma Clinical Trial Services Market Share by Country: (% Share), 2016

Figure 6.21 China Pharma Clinical Trial Services Market: Revenue ($bn), 2016-2027

Figure 6.22 India Pharma Clinical Trial Services Market: Revenue ($bn), 2016-2027

Figure 6.23 Japan Pharma Clinical Trial Services Market: Revenue ($bn), 2016-2027

Figure 6.24 South Korea Pharma Clinical Trial Services Market: Revenue ($bn), 2016-2027

Figure 6.25 Rest of Asia-Pacific (APAC) Pharma Clinical Trial Services Market: Revenue ($bn), 2016-2027

Figure 6.26 Asia-Pacific Pharma Clinical Trial Services Market Revenue by Service: Revenue ($bn), 2016-2027

Figure 6.27 Asia-Pacific Pharma Clinical Trial Services Market by Therapeutic Area: Revenue ($bn), 2016-2027

Figure 6.28 Asia-Pacific Pharma Clinical Trial Services Market by End-Users: Revenue ($bn), 2016-2027

Figure 6.29 Rest of the World (RoW) Pharma Clinical Trial Services Market by Country (% Share), 2016

Figure 6.30 Latin America Pharma Clinical Trial Services Market: Revenue ($bn), 2016-2027

Figure 6.31 Middle East and Africa Pharma Clinical Trial Services Market: Revenue ($bn), 2016-2027

Figure 6.32 Brazil Pharma Clinical Trial Services Market: Revenue ($bn), 2016-2027

Figure 6.33 RoW Pharma Clinical Trial Services Market by Service: Revenue ($bn), 2016-2027

Figure 6.34 RoW Pharma Clinical Trial Services Market by Therapeutic Area: Revenue ($bn), 2016-2027

Figure 6.35 RoW Pharma Clinical Trial Services Market Revenue by End-Users: Revenue ($bn), 2016-2027

Figure 7.1 Market: Drivers and Restraints, 2017-2027

Figure 8.1 Quintiles IMS Holdings Inc. 2016 Annual Revenue by Business Segment: (% Share)

Figure 8.2 LabCorp (Covance Inc.) 2016 Annual Revenue by Business Segments: (% Share)

Figure 8.3 LabCorp Annual Revenue 2012-2016 ($bn)

Figure 8.4 Pharmaceutical Product Development (PPD) 2010 Annual Revenue by Business Segment (% Share)

Figure 8.5 Parexel International Corporation 2016 Annual Revenue by Business Segment (% Share)

Figure 8.6 Parexel International Corporation Annual Revenue 2012- 2016 ($mn)

Figure 8.7 ICON Annual Revenue 2012- 2016 ($bn)

Figure 8.8 INC Research 2016 Annual Revenue by Business Segment: (% Share)

Figure 8.9 INC Research Annual Revenue 2012-2016 ($bn)

Figure 8.10 PRA Health Sciences 2016 Annual Revenue by Business Segment: (% Share)

Figure 8.11 PRA Health Sciences Annual Revenue 2012-2016 ($bn)

Figure 8.12 Charles River Laboratories 2016 Annual Revenue by Business Segment: (% Share)

Figure 8.13 Charles River Laboratories Annual Revenue 2012-2016 ($bn)

Figure 10.1 Global Pharma Clinical Trial Services Market: Revenue ($bn), 2016-2027

Figure 10.2 Pharma Clinical Trial Services Market by Region: Revenue ($bn), 2016-2027

List of Tables

Table 2.1 Founding Members of the ICH

Table 2.2 Types of Adaptive Trial Design

Table 3.1 Breakdown of Pharma Clinical Spending by Phase, 2014

Table 3.2 Breakdown of Pharma Clinical Trial Services by Services

Table 3.3 Table 3.3 Pharma Clinical Trial Services Market by Services: Forecast ($bn, AGR%, CAGR%), 2016-2027

Table 3.4 Table 3.4 Early Phase Clinical Trial Services Market by Region: Forecast ($bn, AGR%, CAGR%), 2016-2027

Table 3.5 Table 3.5 Late Phase Clinical Trial Services Market by Region: Forecast ($bn, AGR%, CAGR%) 2016-2027

Table 3.6 Other Pharma Clinical Trial Services Markets by Region: Forecast ($bn, AGR%, CAGR%) 2016-2027

Table 4.1 Pharma Clinical Trial Services Submarket by End-Users: Forecast ($bn, AGR%, CAGR%), 2016-2027

Table 4.2 Clinical Trial Services Pharma Submarket by Region: Forecast ($bn, AGR%, CAGR%), 2016-2027

Table 4.3 Clinical Trial Services Biotech Companies Submarket by Region: Forecast ($bn, AGR%, CAGR%), 2016-2027

Table 4.4 Clinical Trial Services Other End-Users Submarket by Region: Forecasts ($bn, AGR%, CAGR%), 2016-2027

Table 5.1 Pharma Clinical Trial Services Submarkets by Therapeutic Area: Forecast ($bn, AGR %, CAGR%), 2016-2027

Table 5.2 Cancer Clinical Trial Services Market by Region: Forecast ($bn, AGR%, CAGR%), 2016-2027

Table 5.3 Cardiovascular Diseases Clinical Trial Services Market by Region: Forecast ($bn, AGR%, CAGR%), 2016-2027

Table 5.4 CNS Diseases Clinical Trial Services Market by Region: Forecast ($bn, AGR%, CAGR%), 2016-2027

Table 5.5 Infectious Diseases Clinical Trial Services Market by Region: Forecast ($bn, AGR%, CAGR%), 2016-2027

Table 5.6 Metabolic Diseases Clinical Trial Services Market by Region: Forecast ($bn, AGR%, CAGR%), 2016-2027

Table 5.7 Other Diseases Clinical Trial Services Market by Region: Forecast ($bn, AGR%, CAGR%), 2016-2027

Table 6.1 Regional Pharma Clinical Trial Services Market: Forecast ($bn, AGR% CAGR%), 2016-2027

Table 6.2 U.S. Pharma Clinical Trial Services Market: Forecast ($bn, AGR% CAGR%), 2016-2027

Table 6.3 Rest of North America Pharma Clinical Trial Services Market: Forecast ($bn, AGR% CAGR%), 2016-2027

Table 6.4 North American Pharma Clinical Trial Services Market by Service: Forecast ($bn, AGR% CAGR%), 2016-2027

Table 6.5 North American Pharma Clinical Trial Services Market by Therapeutic Area: Forecast ($bn, AGR% CAGR%), 2016-2027

Table 6.6 North American Pharma Clinical Trial Services Market by End-Users: Forecast ($bn, AGR% CAGR%), 2016-2027

Table 6.7 France Pharma Clinical Trial Services Market: Forecasts ($bn, AGR% CAGR%), 2016-2027

Table 6.8 Germany Pharma Clinical Trial Services Market: Forecasts ($bn, AGR% CAGR%), 2016-2027

Table 6.9 U.K. Pharma Clinical Trial Services Market: Forecasts ($bn, AGR% CAGR%), 2016-2027

Table 6.10 Spain Pharma Clinical Trial Services Market: Forecasts ($bn, AGR% CAGR%), 2016-2027

Table 6.11 Italy Pharma Clinical Trial Services Market: Forecasts ($bn, AGR% CAGR%), 2016-2027

Table 6.12 Russia Pharma Clinical Trial Services Market: Forecasts ($bn, AGR% CAGR%), 2016-2027

Table 6.13 Central and Eastern Europe (CEE) Pharma Clinical Trial Services Market: Forecasts ($bn, AGR% CAGR%), 2016-2027

Table 6.14 Rest of Europe Pharma Clinical Trial Services Market: Forecasts ($bn, AGR% CAGR%), 2016-2027

Table 6.15 European Pharma Clinical Trial Services Market by Service: Forecast ($bn, AGR% CAGR%), 2016-2027

Table 6.16 European Pharma Clinical Trial Services Market by Therapeutic Area: Forecast ($bn, AGR% CAGR%), 2016-2027

Table 6.17 European Pharma Clinical Trial Services Market by End-Users: Forecast ($bn, AGR% CAGR%), 2016-2027

Table 6.18 China Pharma Clinical Trial Services Market: Forecasts ($bn, AGR% CAGR%), 2016-2027

Table 6.19 India Pharma Clinical Trial Services Market: Forecasts ($bn, AGR% CAGR%), 2016-2027

Table 6.20 Japan Pharma Clinical Trial Services Market: Forecasts ($bn, AGR% CAGR%), 2016-2027

Table 6.21 South Korea Pharma Clinical Trial Services Market: Forecasts ($bn, AGR% CAGR%), 2016-2027

Table 6.22 Rest of Asia-Pacific (APAC) Pharma Clinical Trial Services Market: Forecasts ($bn, AGR% CAGR%), 2016-2027

Table 6.23 Asia-Pacific Pharma Clinical Trial Services Market by Service: Forecast ($bn, AGR% CAGR%), 2016-2027

Table 6.24 Asia-Pacific Pharma Clinical Trial Services Market Forecasts by Therapeutic Area: Forecast ($bn, AGR% CAGR%), 2016-2027

Table 6.25 Asia-Pacific Pharma Clinical Trial Services Market by End-Users: Forecast ($bn, AGR% CAGR%), 2016-2027

Table 6.26 Latin America Pharma Clinical Trial Services Market: Forecasts ($bn, AGR% CAGR%), 2016-2027

Table 6.27 Middle East and Africa Pharma Clinical Trial Services Market: Forecasts ($bn, AGR% CAGR%), 2016-2027

Table 6.28 Brazil Pharma Clinical Trial Services Market: Forecasts ($bn, AGR% CAGR%), 2016-2027

Table 6.29 RoW Pharma Clinical Trial Services Market Forecasts by Service: Forecast ($bn, AGR% CAGR%), 2016-2027

Table 6.30 RoW Pharma Clinical Trial Services Market by Therapeutic Area: Forecast ($bn, AGR% CAGR%), 2016-2027

Table 6.31 RoW Pharma Clinical Trial Services Market by End-Users: Forecast ($bn, AGR% CAGR%), 2016-2027

Table 9.1 STEP Analysis of Pharma Clinical Trial Services Market 2016-2027

3C Alliance

Actavis

Adamas Pharmaceuticals

Adheris (an InVentiv Health company)

Agilent Technologies

Agility Clinical

AKESOgen

Akos

Allscripts

Amgen

Aptiv Solutions (now part of ICON plc)

Aptuit

ASAN Medical Center

Assent Consulting

Astellas Pharma

Avista Capital Partners

Baxter International

Bayer

BeijingWits Medical Consulting (part of ICON)

Berry Consultants

BioBay

BioClinica

BioDuro (part of PPD)

BioDuro Biologics

Biogen Idec

Biomedical Systems

BioTrak

Bioxydyn

BML

Boehringer Ingelheim

Bridgepoint Development Capital

Bristol-Myers Squibb

Caprion

Catalent

Catalina Health (part of InVentiv Health)

Celerion

Charles River Laboratories

ClinForce

Clinical Trial Support

Clinigene International

Clinipace Worldwide

ClinStar

CMIC Holdings

CMIC (Beijing) Co

CNS Healthcare

CNS Vital Signs

Cogtest (part of The Cognition Group)

Corex Pharmaceutical

CRI Lifetree (part of PRA Health Sciences)

Cromos Pharma

CROMSOURCE

Cross Country Healthcare Inc

Czura Thornton

Dako (part of Agilent Technologies)

Duke Clinical Research Institute

EF Education First

Eisai

Ekam Imaging

Eli Lilly

EPS Corporation (now EPS Holdings, Inc.)

EPS Holdings, Inc.

Firecrest Clinical (part of ICON)

Forest Pharmaceuticals

Frontage Laboratories

GCP ClinPlus

GE Healthcare

Genstar Capital

Global CNS Research

Global Research Services (GRS)

Główny Urząd Statystyczny (Polish Central Statistical Office)

GSK

Harlan Laboratories (part of Huntingdon Life Sciences)

Hellman & Friedman

Hisun Pharmaceuticals

Huntingdon Life Sciences

i3 Research (part of inVentiv Health)

ICON

ImageIQ

ImmuneHealth

INC Research

Infociencia (part of RPS)

Inspire

Institute for Medical Research Management and Biometrics (IMEREM, part of RPS)

Integrium

inVentiv Health

J&J

Janssen Pharmaceuticals (a subsidiary of J&J)

Japan Pharmaceutical Manufacturers Association (JPMA)

Jasper Clinical Research and Development Inc.

Java Clinical

JCL Bioassay Corporation (part of CMIC Holdings)

Julphar

Kendle (part of INC Research)

Kester Capital

Kforce

Kforce Clinical Research (KCR, part of inVentiv Health)

Kinship Technologies (part of PRA Health Sciences)

KKR

Korea National Enterprise for Clinical Trials (KoNECT)

Kun Tuo (part of Quintiles)

Laboratory Corporation of America (LabCorp)

Les Entreprises du Médicament (LEEM)

LSK Global

MAB Discovery

Malaysian Biotechnology Corporation

Massachusetts General Hospital

Maximax Pharmaceutical Research

MDS Pharma Services (part of INC Research)

MedAvante

Medaxial

Medelis

Medicines and Healthcare products Regulatory Agency (MHRA) [UK]

Medidata Solutions

MediMedia Pharma Solutions (now part of ICON plc)

Medipal Holdings

Medivation

MEK Consulting (part of INC Research)

Merck & Co.

Merck BioVentures

Merck KGaA

Metabolon

MetricStream

Mitsubishi Gas Chemical Company, Inc.

Molecular NeuroImaging

MorphoSys

MPI Research

MRM Proteomics

Myriad Genetics

Mytrus

Nautic Partners

NeuroImage

NextGen Sciences

Nexus Oncology, an Ockham Company (formerly Nexus Oncology)

Novartis

Novotech

Ockham

OCT

Omnicare

Oncobiologics

Ontario Teachers' Pension Plan

Oxford Cancer Biomarkers

Oxford Gene Technology (OGT)

Oxford Outcomes (part of ICON)

Pacific Biomarkers

Paragon Biomedical (part of Clinipace Worldwide)

Paramax International (part of RPS)

Parexel International

PatientsLikeMe

Perceptive Informatics (part of Parexel)

PFC Pharma Focus (part of Clinipace Worldwide)

Pfizer

PharmaNet Development Group (part of inVentiv Health)

Pharmaron

PPD

PRA International

Prana Biotechnology

PriceSpective (part of ICON)

Prodia Clinical Laboratory

Proteome Sciences

ProTrials Research

PSR Orphan Experts

Psychmed (part of The Cognition Group)

QED Clinical Services

Quintiles

Quotient Clinical

RCT Logic

Regulus Pharmaceutical Consulting (part of Clinipace Worldwide)

ReSearch Pharmaceutical Services (RPS, part of PRA International)

Roche

Rules Based Medicine (now Myriad RBM, part of Myriad Genetics)

Samsung

SAS

ShangPharma

Shire

Syngene International

Sugi Medical Co (part of CMIC)

Taijitu Biologics

Targos Molecular Pathology

Tessella

The Carlyle Group

The Clinical Trial Company

The Cognition Group

Theorem Clinical Research

Theradex Systems

Therapharm Recherches (part of RPS)

Thomas H. Lee Partners

Tigermed Consulting

Timaq Medical Imaging (part of ICON)

Trident Clinical Research (part of INC Research)

UCB

University of Manchester

Veeda Clinical Research

Veeva Systems

Vigiun (part of Chiltern International)

VirtualScopics

Warburg Pincus

West Coast Clinical Trials (WCCT)

Worldwide Clinical Research

WuXi AppTec

WuXi PharmaTech

Yungjin Pharmaceutical

Zhejiang Jiang Yuan Tang Biotechnology Co., Ltd

Organizations Mentioned in Report

Administration of Science, Technology and Training (ASST) [Vietnam]

Agência Nacional de Vigilância Sanitária (ANVISA) [Brazil]

Agenzia Italiana del Farmaco (AIFA) [Italy]

Associação Brasileira de CROs (Abracro)

Association for the Accreditation of Human Research Protection Programs (AAHRPP)

Association of Clinical Trial Organisations (ACTO) [Russia]

Center for Biologics Evaluation and Research (CBER) [US]

CenterWatch

Central Drugs Standard Control Organization (CDSCO) [India]

Center for Drug Evaluation (CDE)

China Food and Drug Administration (CFDA)

Chinese Ministry of Commerce

Council for International Organizations of Medical Sciences (CIOMS)

Department of Health [UK]

Department of Health and Human Services [US]

Drug Controller General of India (DCGI)

European Commission

European Federation of Pharmaceutical Industries and Associations (EFPIA)

European Medicines Agency (EMA)

European Parliament

Food and Drug Administration (US FDA)

Hospital Italiano de Buenos Aires

Innovative Medicines Initiative (IMI)

International Cancer Genome Consortium

International Conference of Harmonisation (ICH)

Korea Drug Development Fund (KDDF)

Korea Food and Drug Administration (KFDA)

L'Agence Nationale de Sécurité du Medicament (L’ANSM) [France]

Ministry of Health, Labor and Welfare (MHLW, Japan)

Ministry of Public Health [Russia]

National Cancer Institute (NCI) [US]

National Institute for Health and Care Excellence (NICE) [UK]

National Institutes of Health (NIH) [US]

National Taiwan University Hospital (NTUH)

NHS Research Scotland (NRS)

Pharmaceutical Research and Manufacturers of America (PhRMA)

Pharmaceuticals and Medical Devices Agency (PMDA) [Japan]

Seoul National University Hospital Clinical Trial Center

Shanghai Clinical Research Center

State Food and Drug Administration (SFDA) [China] (now CFDA)

Therapeutic Goods Administration (TGA) [Australia]

World Health Organization (WHO)

World Heart Foundation

Download sample pages

Complete the form below to download your free sample pages for Pharma Clinical Trial Services Market and Industry Forecast 2017-2027

Download sample pages

Complete the form below to download your free sample pages for Pharma Clinical Trial Services Market and Industry Forecast 2017-2027

Case studies

Need customized work?

Report overview

Methodology

Client testimonials

Pharmaceutical industry associations

American Association of Colleges of Pharmacy
American College of Clinical Pharmacy
American Pharmacists Association
American Society for Pharmacy Law
American Society of Consultant Pharmacists
American Society of Health-System Pharmacists
Association of Special Pharmaceutical Manufacturers
Australian College of Pharmacy
Biotechnology Industry Organization
Canadian Pharmacists Association
Canadian Society of Hospital Pharmacists
Chinese Pharmaceutical Association
College of Psychiatric and Neurologic Pharmacists
Danish Association of Pharmaconomists
European Association of Employed Community Pharmacists in Europe
European Medicines Agency
Federal Drugs Agency
General Medical Council
Head of Medicines Agency
International Federation of Pharmaceutical Manufacturers & Associations
International Pharmaceutical Federation
International Pharmaceutical Students’ Federation
Medicines and Healthcare Products Regulatory Agency
National Pharmacy Association
Norwegian Pharmacy Association
Ontario Pharmacists Association
Pakistan Pharmacists Association
Pharmaceutical Association of Mauritius
Pharmaceutical Group of the European Union
Pharmaceutical Society of Australia
Pharmaceutical Society of Ireland
Pharmaceutical Society Of New Zealand
Pharmaceutical Society of Northern Ireland
Professional Compounding Centers of America
Royal Pharmaceutical Society
The American Association of Pharmaceutical Scientists
The BioIndustry Association
The Controlled Release Society
The European Federation of Pharmaceutical Industries and Associations
The European Personalised Medicine Association
The Institute of Clinical Research
The International Society for Pharmaceutical Engineering
The Pharmaceutical Association of Israel
The Pharmaceutical Research and Manufacturers of America
The Pharmacy Guild of Australia
The Society of Hospital Pharmacists of Australia

Connect with us

Visiongain Pharma

Latest Pharma news

Visiongain Publishes Anti-infective Vaccines Market Report 2023-2033

The global Anti-infective Vaccines market is valued at US$48,360.4 million in 2023 and is projected to grow at a CAGR of 6.6% during the forecast period 2023-2033.

21 September 2023

READ

Visiongain Publishes Contract Research Organisations (CROs) Market Report 2023-2033

The global Contract Research Organisations (CROs) market was valued at US$68.9 billion in 2023 and is projected to grow at a CAGR of 10.6% during the forecast period 2023-2033.

14 September 2023

READ

Visiongain Publishes Stem Cell Therapy Contract Manufacturing Market Report 2023-2033

The global Stem Cell Therapy Contract Manufacturing market was valued at US$2,495.1 million in 2022 and is projected to grow at a CAGR of 12.4% during the forecast period 2023-2033.

13 September 2023

READ

Visiongain Publishes Immuno-Oncology Clinical Trials Market Report 2023-2033

Immuno-Oncology Clinical Trials market is valued at US$6,849.8 million in 2023 and is projected to grow at a CAGR of 11.3% during the forecast period 2023-2033.

11 September 2023

READ

Industries > Pharma > Pharma Clinical Trial Services Market and Industry Forecast 2017-2027

Back to Pharma Reports

Pharma Clinical Trial Services Market and Industry Forecast 2017-2027

Early Phase Services, Late Phase Services, Other Services, Pharma, Biotech, Other End-Users, Cancer, Cardiovascular Diseases, CNS, Infectious Diseases, Metabolic Diseases, Other Diseases

Download sample pages

Related reports

Global Medical Device Contract Manufacturing Market Forecast 2018-2028

Global Biosimilars and Follow-On Biologics Market 2019-2029

Global Vaccine Contract Manufacturing Market Report 2019-2029

Global Drug Discovery Outsourcing Market Forecast to 2028

Clinical Trial Supply and Logistics Market for Pharma 2019-2029

Pharmaceutical Contract Manufacturing Market 2018-2028

Pharma Leader Series: Top 50 Pharmaceutical Contract Manufacturing Organisations (CMOs) Market 2018

Download sample pages

Share

Connect with us

Latest Pharma news

Visiongain Publishes Anti-infective Vaccines Market Report 2023-2033

Visiongain Publishes Contract Research Organisations (CROs) Market Report 2023-2033

Visiongain Publishes Stem Cell Therapy Contract Manufacturing Market Report 2023-2033

Visiongain Publishes Immuno-Oncology Clinical Trials Market Report 2023-2033

Our Clients